Evidence map›Paper›PMID 38859995›Full record

ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2024

Serum Gamma Glutamyltransferase: A Biomarker for Identifying Postprandial Hypertriglyceridemia.

Kunjie Zheng, Xiaolong Li, Yihua Rong, Xuejing Wang, Liping Hou, Wei Gu, Xiaoyu Hou, Yunpeng Guan, Lifang Liu, Jianlin Geng and 1 more

Abstract read
In one paragraph

Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Role of ChREBP-PPARα-FGF21 Axis in Metabolic Dysfunction of MASLD.International journal of molecular sciences · 2025
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Kunjie ZhengDepartment of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.
Xiaolong LiDepartment of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.ORCID 0009-0004-6431-6036
Yihua RongDepartment of Endocrinology, Hengshui People's Hospital, Hengshui, Hebei, People's Republic of China.
Xuejing WangHengshui People's Hospital Statistical Office, Hengshui, Hebei, People's Republic of China.
Liping HouDepartment of Endocrinology, Hengshui People's Hospital, Hengshui, Hebei, People's Republic of China.
Wei GuDepartment of Endocrinology, Hengshui People's Hospital, Hengshui, Hebei, People's Republic of China.
Xiaoyu HouDepartment of Endocrinology, Hebei General Hospital, Shijiazhuang, Hebei, People's Republic of China.
Yunpeng GuanDepartment of Endocrinology, Shijiazhuang People's Hospital, Shijiazhuang, Hebei Province, People's Republic of China.
Lifang LiuDepartment of Endocrinology, Baoding First Central Hospital, Baoding, Hebei, People's Republic of China.
Jianlin GengDepartment of Endocrinology, Hengshui People's Hospital, Hengshui, Hebei, People's Republic of China.
Guangyao SongDepartment of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Elevated serum gamma-glutamyltranspeptidase (GGT) is an independent marker of the activation of systemic inflammation, while conditions associated with elevated triglyceride (TG) levels, such as type 2 diabetes, non-alcoholic fatty liver disease, obesity, and metabolic syndrome, are associated with an increased inflammatory burden. Moreover, serum liver enzymes (GGT, alanine aminotransferase [ALT], aspartate aminotransferase [AST], and alkaline phosphatase [ALP]) are associated with metabolic syndrome and its components, including hypertriglyceridemia. However, the relationship between liver enzymes and postprandial hypertriglyceridemia (PHTG) remains unclear. Therefore, in this study we conducted oral fat tolerance tests (OFTTs) to understand the differences in serum liver enzyme levels among individuals with different lipid tolerance levels and their correlation with PHTG. Patients and Methods: For the OFTT, we enrolled 202 non-diabetic volunteers whose fasting triglyceride (TG) levels were less than 1.7 mmol/L in this case-control study. The participants were categorized into two groups according to the TG levels at the 0- and 4-h OFTT: a postprandial normal TG (PNTG) group and a PHTG group. Routine fasting serum biochemical indices, liver enzyme (GGT, ALT, AST, and ALP) levels, and 0- and 4-h OFTT lipid levels were assessed. Results: The PHTG group had significantly higher serum GGT and ALT levels and a lower AST/ALT ratio than those in the PNTG group. However, no significant difference was observed in AST and ALP levels compared with the PNTG group. After adjusting for major confounders, logistic regression analysis indicated a significant correlation between serum GGT and PHTG (odds ratio = 1.168, P < 0.001), but not with ALT level, AST level, AST/ALT ratio, and ALP level. The receiver operating characteristic curve analysis demonstrated that the serum GGT level was an effective predictor of PHTG. Conclusion: Serum GGT levels are significantly associated with PHTG risk and serve as an effective biomarker for early identification.

Indexed as

alanine aminotransferasealkaline phosphataseaspartate aminotransferasegamma-glutamyl transferaseinflammationoral fat tolerance testtriglyceride

Identifiers

PMID38859995
PMCPMC11164083

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.